Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma PatientsHadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, et al.
Frontiers in Microbiology|January 22, 2026
Gene and function diversity-area relationships in the inflammatory bowel disease fecal and mucosal microbiomeFubing Yu, Jiyang Song, Linyi Qi, et al.
Surgical Endoscopy|July 31, 2023
Resolution and recurrence of anemia following repair of paraesophageal herniasTimothy Baumgartner, Steven Liu, Wendy Li, et al.
Archives of Dermatological Research|November 24, 2021
Association between baseline insulin resistance and psoriasis incidence: the Women's Health InitiativeAlfred A Chan, Houmin Li, Wendy Li, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
Carbohydrate Polymers|November 30, 2025
Response of starch molecular structure and functional properties of novel perennial Tartary buckwheat lines to different nitrogen and phosphorus fertilizer levelsFan Yang, Jiaqi Qiao, Tong Li, et al.
Frontiers in Microbiology|October 13, 2022
Diversity-scaling analysis of human breast milk microbiomes from population perspectiveHongju Chen, Bin Yi, Yuting Qiao, et al.
Lancet (London, England)|May 10, 2016
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trialDinesh Khanna, Christopher P Denton, Angelika Jahreis, et al.
Healthcare Quarterly (Toronto, Ont.)|February 26, 2022
Using Case Costing to Evaluate the Potential Impact of a Reintegration Unit on an Acute-Care Hospital's Capacity and ResourcesIvy Cheng, Clare L Atzema, Debra Carew, et al.
Pageof 15